Sun Pharma share price slips 5% after Q4 results; check key numbers here

Sun Pharma share price: Pharmaceutical company Sun pharma shares were under pressure on Friday, May 23, 2025, with the scrip dropping up to 4.86 per cent lower to an intraday low of ₹1,636.30 per share.
By 9:24 AM, Sun Pharma shares continued to trade near day's low level, down 4.66 per cent lower at ₹1,639.90 per share. In comparison, BSE Sensex was trading 0.08 per cent higher at 81,015.07 level.
Why did Sun Pharma share price drop in trade?
Sun Pharma share price dropped after the company posted a mixed bag of results in the March quarter of financial year 2025 (Q4FY25).
The company's net profit dropped 19 per cent year-on-year (Y-o-Y) to ₹2,153.9 crore in the March quarter of financial year 2025 (Q4FY25), from ₹2,658.74 crore in the same quarter last year (Q4FY24).
Revenue from operations, however, increased 8.49 per cent Y-o-Y to ₹12,815.58 crore, up from ₹11,813.33 crore in Q4FY24.
Sun Pharma dividend
Sun Pharma's board has recommended a final dividend of ₹5.5 per equity share of face value ₹1 each, subject to shareholders' approval at the upcoming Annual General Meeting.
The company has fixed Monday, July 7, 2025 as Record Date for the purpose of determining the Members eligible to receive the final dividend.
"Our businesses delivered a robust performance for the year, driven by improving market share in India and growth in Global Specialty. The nearterm pipeline in Global Specialty is promising, with products such as Leqselvi and Unloxcyt—the latter through our recently announced Checkpoint acquisition—offering significant improvements in patient care. We look forward to Specialty becoming an increasingly important part of our business," said Dilip Shanghvi, chairman and managing director, Sun Pharma.
About Sun Pharma
Founded in 1983, Sun Pharmaceutical Industries is the world's fourth-largest specialty generic pharmaceutical company, with global revenues of $5.8 billion. With a presence in over 100 countries and 41 manufacturing facilities worldwide, Sun Pharma delivers high-quality, affordable medicines trusted by healthcare professionals and patients alike.
Its diverse portfolio includes over 2,000 high-quality molecules across generics, branded generics, specialty and complex products, OTC, ARVs, APIs, and intermediates—spanning multiple dosage forms such as tablets, capsules, injectables, inhalers, and topical formulations.
The company is ranked among the top generic pharmaceutical firms in the US, especially in the dermatology space, and maintains a strong presence across key emerging markets like Brazil, Mexico, Russia, and South Africa.
The company consistently invests 6–8 per cent of its global revenues in R&D, supported by a team of over 3,000 scientists, driving innovation in areas like liposomal formulations, lyophilised injections, and controlled-release systems.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Economic Times

17 minutes ago

• Economic Times

Stock market update: Nifty Bank index falls 0.54% in a weak market

NEW DELHI: The Nifty Bank index traded negative around 10:58AM(IST)on Monday in a weak market. ADVERTISEMENT IDFC First Bank Ltd.(up 0.93 per cent), Au Small Finance Bank Ltd.(up 0.71 per cent) and Punjab National Bank(up 0.17 per cent) were among the top gainers. Axis Bank Ltd.(down 0.85 per cent), ICICI Bank Ltd.(down 0.76 per cent), HDFC Bank Ltd.(down 0.73 per cent), IndusInd Bank Ltd.(down 0.7 per cent) and State Bank of India(down 0.7 per cent) were the top losers on the index. The Nifty Bank index was down 0.54 per cent at 55949.05 at the time of writing this report. Benchmark NSE Nifty50 index was down 196.81 points at 24915.6, while the BSE Sensex was down 668.33 points at 81739.84. Among the 50 stocks in the Nifty index, 9 were trading in the green, while 41 were in the red. ADVERTISEMENT Shares of Vodafone Idea, Ola Electric Mobilit, RattanIndia Power, Zee Ent. and YES Bank were among the most traded shares on the NSE. Shares of Madhya Bharat Agro, SRM Contractors, Apollo Micro Systems, Quality Power Electr and Reliance Naval & Engg hit their fresh 52-week highs in today's trade, while Osia Hyper Retail, Omkar Speciality, Lasa Supergenerics, Navkar Builders and Sadhana Nitro hit fresh 52-week lows in trade. (You can now subscribe to our ETMarkets WhatsApp channel)

Mint

18 minutes ago

• Mint

Indian benchmarks drop 1% as investors fret over heightened Mideast tensions

(Reuters) -India's equity benchmarks fell 1% on Monday after U.S. attacks on Iranian nuclear sites fuelled fears of a further escalation in Middle East tensions and pushed oil prices to a five-month high. The Nifty 50 and the BSE Sensex were down 0.9% each at 24,890.03 points and 81,659.09 points, respectively, as of 10:37 a.m. IST. All 13 major sectors traded lower. The broader mid-caps fell 0.2% and small-caps were flat. The U.S. bombed Iranian nuclear sites over the weekend, joining Israel in the biggest Western military action against the Islamic Republic since the 1979 revolution. Most Asian stocks fell on Monday, with the MSCI Asia ex Japan down more than 1%. Oil prices briefly hit a five-month high, while the focus remains on a potential military response from Iran. [MKTS/GLOB] "Worries over potential supply disruptions from Strait of Hormuz is driving the sentiment," said Vinit Bolinjkar, head of research at Ventura Securities. About a fifth of the world's total oil consumption passes through the strait, which lies between Oman and Iran. Higher crude oil prices are a negative for India, which depends heavily on imports for its energy requirements, as they could stoke inflation and widen the fiscal deficit. Still, UBS said it does not see a prolonged disruption to oil supplies. "We believe that near-term downside in stocks could represent an opportunity for investors who are underallocated to equities to build positions," the brokerage said. Meanwhile, IT stocks shed 1.8% after Accenture posted a third consecutive quarter of yearly decline in outsourcing orders as a cutback in U.S. government spending and tariff uncertainty pressured economic growth. Indian IT firms get a significant chunk of their revenue from the U.S. In contrast, small finance banks rose after the central bank reduced the mandated portion of lending to priority sectors to 60% from 75%. (Reporting by Vivek Kumar M; Editing by Sonia Cheema and Mrigank Dhaniwala)

Business Standard

21 minutes ago

• Business Standard

₹80-crore order from Ather Energy lifts Interarch Building share price 4%

Interarch Building share price today: Interarch Building Solutions (Interarch Building) shares were in demand in an overall weak market on the first trading day of the week i.e. Monday, June 23, 2025, with the stock rallying up to 3.83 per cent to an intraday high of ₹2,140 per share. At 10:45 AM, Interarch Building shares continued to trade near day's high levels, up 3.78 per cent at ₹2,139 per share. In comparison, BSE Sensex was trading 0.85 per cent lower at 81,709.33 levels. What fueled the rise in Interarch Building share price? Interarch Building shares jumped in trade today after the company announced that it has secured an order worth ₹80 crore from Ather Energy. In an exchange filing, Interarch Building said, 'We wish to inform you that the Company has secured an order from M/s Ather Energy Ltd. The formal purchase order is currently awaited.' Under the terms of the order, Interarch Building will be responsible for design, engineering, manufacturing, supply and erection of pre-engineered steel building systems. According to the company, it has received a 10 per cent advance payment along with the order. The project is scheduled to be completed within nine months. At the beginning of the month, the company received a purchase order worth ₹45 crore from an automobile original equipment manufacturer (OEM). ALSO READ | About Interarch Building Interarch Building Solutions is among the leading providers of turnkey pre-engineered steel construction solutions in India. Established in 1983, the company offers end-to-end services including design, engineering, manufacturing, and on-site project management for pre-engineered steel buildings. With decades of experience, Interarch has built a strong reputation for its expertise in metal interiors and customised PEB solutions catering to diverse sectors such as industrial, commercial, and infrastructure. Interarch Building operates five strategically located manufacturing facilities in Uttarakhand (Pantnagar and Kichha), Tamil Nadu (Sriperumbudur), and Andhra Pradesh (Athivaram). Its dedicated arm, Interarch Infrastructure, focuses on delivering complex heavy steel and large-scale infrastructure solutions across India. Last checked on BSE, Interarch Building's market capitalisation stood at ₹3,542.75 crore. The company falls under the BSE SmallCap index.